# Boxer Capital's Biotech Investments: 12 Startups in Its Portfolio (2026)

> The 12 Biotech startups Boxer Capital has backed, by stage: $1.8B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/boxer-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series B

6

- [Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics)
- [SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics)
- [Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals)
- [*I* Ideaya](https://millionrounds.com/company/ideaya)
- [*PT* Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics)
- [*AP* Attune Pharmaceuticals](https://millionrounds.com/company/attune-pharmaceuticals)

## Series C and later

4

- [*A* Atreca](https://millionrounds.com/company/atreca)
- [*BD* Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics)
- [*PP* PMV Pharma](https://millionrounds.com/company/pmv-pharma)
- [*S* Sojournix](https://millionrounds.com/company/sojournix)

## Stage not reported

2

- [CiVi Biopharma](https://millionrounds.com/company/civi-biopharma)
- [Telesta Therapeutics](https://millionrounds.com/company/telesta-therapeutics)

## Segment by segment

### Series B

6 startups · $1.2B raised

- [**Akero Therapeutics**](https://millionrounds.com/company/akero-therapeutics) Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state. United States $502M
- [**SpringWorks Therapeutics**](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. United States $400M
- [**Milestone Pharmaceuticals**](https://millionrounds.com/company/milestone-pharmaceuticals) Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases. Canada $110M
- [*I* **Ideaya**](https://millionrounds.com/company/ideaya) United States $94M
- [*PT* **Prevail Therapeutics**](https://millionrounds.com/company/prevail-therapeutics) United States $50M
- [*AP* **Attune Pharmaceuticals**](https://millionrounds.com/company/attune-pharmaceuticals) Attune Pharmaceuticals develops novel orally-administered small-molecule therapies for the treatment of genetic disorders. United States $23M

### Series C and later

4 startups · $504M raised

- [*A* **Atreca**](https://millionrounds.com/company/atreca) Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. United States $313M
- [*BD* **Black Diamon Therapeutics**](https://millionrounds.com/company/black-diamon-therapeutics) United States $85M
- [*PP* **PMV Pharma**](https://millionrounds.com/company/pmv-pharma) United States $62M
- [*S* **Sojournix**](https://millionrounds.com/company/sojournix) Sojournix is a clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of neuroend United States $44M

### Stage not reported

2 startups · $118M raised

- [**CiVi Biopharma**](https://millionrounds.com/company/civi-biopharma) CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular. United States $89M
- [**Telesta Therapeutics**](https://millionrounds.com/company/telesta-therapeutics) Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics. Canada $29M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Boxer Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Co-investors **Who invests with Boxer Capital** 20 co-investors](https://millionrounds.com/portfolio-maps/boxer-capital-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio)

## Raising from investors like Boxer Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)